These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 473068)

  • 21. Therapeutic efficacy of cyclophosphamide as a function of its metabolism.
    Sladek NE
    Cancer Res; 1972 Mar; 32(3):535-42. PubMed ID: 5061308
    [No Abstract]   [Full Text] [Related]  

  • 22. Limb development in mouse embryos. III. Cellular events underlying the determination of altered skeletal patterns following treatment with 5'fluoro-2-deoxyuridine.
    Knudsen TB; Kochhar DM
    Teratology; 1981 Apr; 23(2):241-51. PubMed ID: 6455767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Embryonic limb bud organ culture in assessment of teratogenicity of environmental agents.
    Kochhar DM
    Teratog Carcinog Mutagen; 1982; 2(3-4):303-12. PubMed ID: 6130629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retinoic acid respecifies limb bud cells in vitro.
    Hayamizu TF; Bryant SV
    J Exp Zool; 1992 Oct; 263(4):423-9. PubMed ID: 1402740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Modified effect of the induction of the mixed function oxidase system on the cytogenetic action of cyclophosphamide].
    Zhurkov VS; Merkur'eva RV; Burmantova NP; Votiakov AV; Vyskubenko IF; Sycheva LP
    Vestn Akad Med Nauk SSSR; 1985; (1):54-8. PubMed ID: 3976287
    [No Abstract]   [Full Text] [Related]  

  • 26. The in vitro teratogenicity of cyclophosphamide in rat embryos.
    Greenaway JC; Fantel AG; Shepard TH; Juchau MR
    Teratology; 1982 Jun; 25(3):335-43. PubMed ID: 7112435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of mixed-function oxidase inducers on the in vitro metabolism of N'-nitrosonornicotine by rat and hamster liver microsomes.
    McCoy GD; Chen CB; Hecht SS
    Drug Metab Dispos; 1981; 9(2):168-9. PubMed ID: 6113118
    [No Abstract]   [Full Text] [Related]  

  • 28. Cyclophosphamide teratogenesis: evidence for compensatory responses to induced cellular toxicity.
    Francis BM; Rogers JM; Sulik KK; Alles AJ; Elstein KH; Zucker RM; Massaro EJ; Rosen MB; Chernoff N
    Teratology; 1990 Nov; 42(5):473-82. PubMed ID: 2278024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stereoselectivity in the metabolism of the enantiomers of cyclophosphamide in mice, rats, and rabbits.
    Cox PJ; Farmer PB; Jarman M; Kinas RW; Stec WJ
    Drug Metab Dispos; 1978; 6(6):617-22. PubMed ID: 33022
    [No Abstract]   [Full Text] [Related]  

  • 30. Application of a metabolizing system as an adjunct to the rat whole embryo culture.
    Luijten M; Verhoef A; Westerman A; Piersma AH
    Toxicol In Vitro; 2008 Aug; 22(5):1332-6. PubMed ID: 18514478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cellular events and the pattern of p53 protein expression following cyclophosphamide-initiated cell death in various organs of developing embryo.
    Torchinsky A; Ivnitsky I; Savion S; Shepshelovich J; Gorivodsky M; Fein A; Carp H; Schwartz D; Frankel J; Rotter V; Toder V
    Teratog Carcinog Mutagen; 1999; 19(5):353-67. PubMed ID: 10495452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential effects of 4-hydroperoxycyclophosphamide on limb development in vitro.
    Hales BF; Jain R
    Teratology; 1986 Dec; 34(3):303-11. PubMed ID: 2432673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Susceptible stages and abnormal morphogenesis in the developing mouse limb, analysed in organ culture after transplacental exposure to vitamin A (retinoic acid).
    Kochhar DM; Aydelotte MB
    J Embryol Exp Morphol; 1974 Jun; 31(3):721-34. PubMed ID: 4448947
    [No Abstract]   [Full Text] [Related]  

  • 34. Teratology testing: I. Development and status of short-term prescreens. II. Biotransformation of teratogens as studied in whole embryo culture.
    Shepard TH; Fantel AG; Mirkes PE; Greenaway JC; Faustman-Watts E; Campbell M; Juchau MR
    Prog Clin Biol Res; 1983; 135():147-64. PubMed ID: 6364154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioactivation of thalidomide by a monkey liver fraction in a rat limb culture system.
    Shepard TH; Shiota K
    Prog Clin Biol Res; 1983; 110 Pt A():377-85. PubMed ID: 6828503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Teratogenicity of cyclophosphamide in a coupled microsomal activating/embryo culture system.
    Kitchin KT; Schmid BP; Sanyal MK
    Biochem Pharmacol; 1981 Jan; 30(1):59-64. PubMed ID: 7213412
    [No Abstract]   [Full Text] [Related]  

  • 37. Teratogenic interactions of consecutively administered cortisone and cyclophosphamide.
    Dostál M
    Folia Morphol (Praha); 1985; 33(2):201-8. PubMed ID: 4029831
    [No Abstract]   [Full Text] [Related]  

  • 38. Development of a mouse embryo limb bud cell culture system for the estimation of chemical teratogenic potential.
    Guntakatta M; Matthews EJ; Rundell JO
    Teratog Carcinog Mutagen; 1984; 4(4):349-64. PubMed ID: 6149628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutagenicity of the dihydrodiols and bay-region diol-epoxides of benzo(c)phenanthrene in bacterial and mammalian cells.
    Wood AW; Chang RL; Levin W; Ryan DE; Thomas PE; Croisy-Delcey M; Ittah Y; Yagi H; Jerina DM; Conney AH
    Cancer Res; 1980 Aug; 40(8 Pt 1):2876-83. PubMed ID: 6992991
    [No Abstract]   [Full Text] [Related]  

  • 40. Identification of aldophosphamide as a metabolite of cyclophosphamide in vitro and in vivo in humans.
    Fenselau C; Kan MN; Rao SS; Myles A; Friedman OM; Colvin M
    Cancer Res; 1977 Aug; 37(8 Pt 1):2538-43. PubMed ID: 872080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.